Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Velimir A Luketic

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Clinics in Liver Disease|April 6, 2004
Benign recurrent intrahepatic cholestasisVelimir A Luketic, Mitchell L Shiffman
Gastroenterology & Hepatology|April 7, 2017
Management Of Primary Sclerosing CholangitisBimaljit S Sandhu, Velimir A Luketic
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 17, 2020
Parvovirus-Induced Adult-Onset Still Disease Presenting With Elevated Liver TransaminasesSamer Al-Humadi, Dennis Kumral, Fei-Pi Lin, et al.
Clinical & Developmental Immunology|November 24, 2004
A review of the physiological and immunological functions of biliary epithelial cells: targets for primary biliary cirrhosis, primary sclerosing cholangitis and drug-induced ductopeniasChih-Te Wu, Paul A Davis, Velimir A Luketic, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 30, 2015
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver diseaseMohammad S Siddiqui, Kavish R Patidar, Sherry Boyett, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2008
A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitisJonathan T Hlivko, Mitchell L Shiffman, R Todd Stravitz, et al.
The American Journal of Gastroenterology|February 27, 2007
Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3Mitchell L Shiffman, Anastasios A Mihas, Farida Millwala, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 8, 2004
A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African AmericansRichard K Sterling, R Todd Stravitz, Velimir A Luketic, et al.
The American Journal of Gastroenterology|May 7, 2004
Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?Richard K Sterling, Charlotte M Hofmann, Velimir A Luketic, et al.
The American Journal of Gastroenterology|September 23, 2003
Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndromeArun J Sanyal, Melissa J Contos, Richard K Sterling, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Clinics in Liver Disease|April 6, 2004
Benign recurrent intrahepatic cholestasisVelimir A Luketic, Mitchell L Shiffman
Gastroenterology & Hepatology|April 7, 2017
Management Of Primary Sclerosing CholangitisBimaljit S Sandhu, Velimir A Luketic
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 17, 2020
Parvovirus-Induced Adult-Onset Still Disease Presenting With Elevated Liver TransaminasesSamer Al-Humadi, Dennis Kumral, Fei-Pi Lin, et al.
Clinical & Developmental Immunology|November 24, 2004
A review of the physiological and immunological functions of biliary epithelial cells: targets for primary biliary cirrhosis, primary sclerosing cholangitis and drug-induced ductopeniasChih-Te Wu, Paul A Davis, Velimir A Luketic, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 30, 2015
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver diseaseMohammad S Siddiqui, Kavish R Patidar, Sherry Boyett, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2008
A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitisJonathan T Hlivko, Mitchell L Shiffman, R Todd Stravitz, et al.
The American Journal of Gastroenterology|February 27, 2007
Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3Mitchell L Shiffman, Anastasios A Mihas, Farida Millwala, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 8, 2004
A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African AmericansRichard K Sterling, R Todd Stravitz, Velimir A Luketic, et al.
The American Journal of Gastroenterology|May 7, 2004
Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?Richard K Sterling, Charlotte M Hofmann, Velimir A Luketic, et al.
The American Journal of Gastroenterology|September 23, 2003
Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndromeArun J Sanyal, Melissa J Contos, Richard K Sterling, et al.
Pageof 7